Mottola Frank's Form 4 filing
Supernus Pharmaceuticals, Inc. (SUPN) · filed Dec 22, 2025
- Accession no.
- 0001628280-25-058506
- Filed
- Dec 22, 2025
- Trade date
- Dec 19, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.01M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mottola FrankCIK 0001804567 | Officer (SVP, Chief Tech. Ops. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +5,000 | $39.40 | +$197,000 | 20,496 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −5,000 | $50.22 | −$251,100 | 15,496 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseAcquired | +15,000 | $25.30 | +$379,500 | 30,496 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −15,000 | $50.47 | −$757,050 | 15,496 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Dec 19, 2025 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.